Genomics England Project Reaches Major Milestone That Could Revolutionize Genetic Rare Disease Treatment
source: pixabay.com

Genomics England Project Reaches Major Milestone That Could Revolutionize Genetic Rare Disease Treatment

According to a story from news-medical.net, the Genomics England company, which was founded as a subsidiary of the UK's Department of Health and Social Care in 2013, announced recently that…

Continue Reading Genomics England Project Reaches Major Milestone That Could Revolutionize Genetic Rare Disease Treatment
Investigational Therapy for Duchenne Muscular Dystrophy is Seeking Orphan Drug Designation
source: pixabay.com

Investigational Therapy for Duchenne Muscular Dystrophy is Seeking Orphan Drug Designation

According to a story from financialbuzz.com, the biotechnology company BIOPHYTIS has submitted documentation for orphan drug designation from the European Medicines Agency (EMA). This designation will be for Sarconeos, a…

Continue Reading Investigational Therapy for Duchenne Muscular Dystrophy is Seeking Orphan Drug Designation
Nanotechnology Could Become a Breakthrough Treatment For Patients With Rare Cancers
source: pixabay.com

Nanotechnology Could Become a Breakthrough Treatment For Patients With Rare Cancers

According to a story from biospace.com, a research team from the National Cancer Institute was able to successfully deliver an experimental nanomedicine to mice that had rare cancers such as…

Continue Reading Nanotechnology Could Become a Breakthrough Treatment For Patients With Rare Cancers
Researchers Use New Method With Electronic Health Records To Identify Genetic Diseases
Source: Pixabay

Researchers Use New Method With Electronic Health Records To Identify Genetic Diseases

Vanderbilt University Medical Center researchers have discovered a new method of searching existing electronic medical records to help identify genetic diseases in larger populations, reported EurekAlert!. Many people who may…

Continue Reading Researchers Use New Method With Electronic Health Records To Identify Genetic Diseases
An Experimental Treatment for Fragile X and Angelman Syndromes Gets Fast Track Designation
Source: Pixabay

An Experimental Treatment for Fragile X and Angelman Syndromes Gets Fast Track Designation

According to a story from pharmiweb.com, the pharmaceutical company Ovid Therapeutics announced recently that the U.S. Food and Drug Administration (FDA) has given its drug candidate OV101 Fast Track designation…

Continue Reading An Experimental Treatment for Fragile X and Angelman Syndromes Gets Fast Track Designation
A Mother and Daughter in India With Muscular Dystrophy Have Started A Hunger Strike To Demand Treatment and Support
source: pixabay.com

A Mother and Daughter in India With Muscular Dystrophy Have Started A Hunger Strike To Demand Treatment and Support

According to a story from aninews.in, mother Shashi Mishra and her daughter Anamika Mishra have staged a hunger strike in a desperate move to receive treatment for their muscular dystrophy.…

Continue Reading A Mother and Daughter in India With Muscular Dystrophy Have Started A Hunger Strike To Demand Treatment and Support
An Apple Watch Strap is in Development That Could Detect Hyperkalemia
source: pixabay.com

An Apple Watch Strap is in Development That Could Detect Hyperkalemia

According to a story from engadget.com, the tech company AliveCor, known for its KardiaBand device for Apple Watch, is currently developing new capabilities for its innovative watch strap. Currently, the…

Continue Reading An Apple Watch Strap is in Development That Could Detect Hyperkalemia
Advances in Care Are Allowing Duchenne Muscular Dystrophy Patients to Live Longer, But With A Longer Life Comes New Challenges
source: pixabay.com

Advances in Care Are Allowing Duchenne Muscular Dystrophy Patients to Live Longer, But With A Longer Life Comes New Challenges

According to a story from sciencedaily.com, new and improved standards of treatment are allowing patients with Duchenne muscular dystrophy to have longer lifespans than in the past. By all accounts,…

Continue Reading Advances in Care Are Allowing Duchenne Muscular Dystrophy Patients to Live Longer, But With A Longer Life Comes New Challenges
A Young Girl With Hydrocephalus Will Have to Travel Thousands of Miles For Treatment
https://pixabay.com/en/airplane-aircraft-airline-plane-145889/

A Young Girl With Hydrocephalus Will Have to Travel Thousands of Miles For Treatment

According to a story from the Herald Sun, Matilda Mahon, an eighteen month old girl from Australia, will need to travel to the United States in order to receive treatment…

Continue Reading A Young Girl With Hydrocephalus Will Have to Travel Thousands of Miles For Treatment
This Cannabis Research Company Just Received A License to Grow Cannabis For Treatment Development
Source: www.pixabay.com

This Cannabis Research Company Just Received A License to Grow Cannabis For Treatment Development

Just recently, MMJ International Holdings announced that MMJ Bioscience has received proper Canadian licensing to grow cannabis specifically to develop cannabinoid medicines to treat patients battling multiple sclerosis and Huntington's…

Continue Reading This Cannabis Research Company Just Received A License to Grow Cannabis For Treatment Development
Patient Organizations Are Starting to Risk Their Financial Ties to Big Pharma by Opposing High Drug Prices
source: pixabay.com

Patient Organizations Are Starting to Risk Their Financial Ties to Big Pharma by Opposing High Drug Prices

According to a story from Xconomy National, some patient advocacy organizations are beginning to speak out about exorbitantly high drug prices despite the fact that many of them receive funding…

Continue Reading Patient Organizations Are Starting to Risk Their Financial Ties to Big Pharma by Opposing High Drug Prices
Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment
source: pixabay.com

Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment

According to a story from The European Society For Medical Oncology, a recent study shows that young adults and teenagers are less likely to adhere to follow-up guidelines following treatment…

Continue Reading Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment
#PutPatientsFirst : The Trump Administration Wants to Allow Medical Personnel to Withhold Service Based on “Religious” Beliefs
source: pixabay.com

#PutPatientsFirst : The Trump Administration Wants to Allow Medical Personnel to Withhold Service Based on “Religious” Beliefs

According to a story from guttmacher.org, the U.S. Department of Health and Human Services proposed a host of new regulations purported to enforce over 20 federal provisions related to "conscience…

Continue Reading #PutPatientsFirst : The Trump Administration Wants to Allow Medical Personnel to Withhold Service Based on “Religious” Beliefs
These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable
source: pixabay.com

These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable

According to a story from PR Newswire, the pharmaceutical companies Sanofi and and Regeneron Pharmaceuticals are implementing a plan to make Praluent injections more accessible and affordable for patients with…

Continue Reading These Drug Companies Are Trying to Make Treatment for Familial Hypercholestrolemia More Affordable
A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA
source: pixabay.com

A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA

According to a story from pharmpro.com, the pharmaceutical company Abeona Therapeutics announced that it has been given Rare Pediatric Disease Designation for its ABO-202 program by the U.S. Food and…

Continue Reading A Treatment for Batten Disease Was Given Rare Pediatric Disease Designation from the FDA
The FDA Gave Orphan Drug Designation to an Investigational Treatment For Cystic Fibrosis
Source: Pixabay

The FDA Gave Orphan Drug Designation to an Investigational Treatment For Cystic Fibrosis

According to a story from Financial Buzz, the pharmaceutical company Proteostasis Therapeutics recently announced that the company's experimental treatment PTI-428 was granted Orphan Drug Designation by the FDA. PTI-428 is…

Continue Reading The FDA Gave Orphan Drug Designation to an Investigational Treatment For Cystic Fibrosis